Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), and pharmacodynamics of drugs administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments, which measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program, which takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor. In addition, it offers MedChem Studio, a software tool for data mining and designing new molecules; KIWI, a cloud-based Web application, which organizes, processes, maintains, and communicates the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; and DILIsym, a software that is used to investigate the likelihood that a known drug molecule would cause injury to the liver. Further, the company provides consulting services ranging from early drug discovery through preclinical and clinical trial data analysis, and for submissions to regulatory agencies; and population modeling and simulation contract research services for the pharmaceutical and biotechnology industries. Additionally, it offers its pharmaceutical/chemistry software to pharmaceutical, biotechnology, agrochemical, and food companies. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Computer integrated systems design
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:SLP
Previous Symbol
CUSIPN/A
Phone661-723-7723
Debt
Debt-to-Equity RatioN/A
Current Ratio3.70
Quick Ratio3.70
Price-To-Earnings
Trailing P/E Ratio37.20
Forward P/E Ratio35.77
P/E GrowthN/A
Sales & Book Value
Annual Sales$29.67 million
Price / Sales10.92
Cash Flow$0.6173 per share
Price / Cash30.13
Book Value$1.84 per share
Price / Book10.11
Profitability
EPS (Most Recent Fiscal Year)$0.50
Net Income$8.93 million
Net Margins30.11%
Return on Equity24.97%
Return on Assets17.82%
Miscellaneous
Employees95
Outstanding Shares17,420,000
Market Cap$352.24 million
OptionableOptionable
Simulations Plus (NASDAQ:SLP) Frequently Asked Questions
What is Simulations Plus' stock symbol?
Simulations Plus trades on the NASDAQ under the ticker symbol "SLP."
How often does Simulations Plus pay dividends? What is the dividend yield for Simulations Plus?
Simulations Plus announced a quarterly dividend on Tuesday, October 23rd. Shareholders of record on Thursday, November 1st will be paid a dividend of $0.06 per share on Thursday, November 8th. This represents a $0.24 annualized dividend and a yield of 1.18%. The ex-dividend date is Wednesday, October 31st. View Simulations Plus' Dividend History.
How were Simulations Plus' earnings last quarter?
Simulations Plus, Inc. (NASDAQ:SLP) posted its quarterly earnings data on Wednesday, November, 14th. The technology company reported $0.07 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.06 by $0.01. The technology company had revenue of $6.70 million for the quarter, compared to analysts' expectations of $5.98 million. Simulations Plus had a net margin of 30.11% and a return on equity of 24.97%. View Simulations Plus' Earnings History.
When is Simulations Plus' next earnings date?
Has Simulations Plus been receiving favorable news coverage?
Media coverage about SLP stock has trended somewhat positive recently, according to InfoTrie. The research firm identifies positive and negative media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Simulations Plus earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave media headlines about the technology company a news buzz of 8.0 out of 10, indicating that recent media coverage is very likely to have an effect on the company's share price in the near term.
Who are some of Simulations Plus' key competitors?
Some companies that are related to Simulations Plus include Sykes Enterprises (SYKE), Nextgen Healthcare (NXGN), Unisys (UIS), Onespan (OSPN), Ribbon Communications (RBBN), KEYW (KEYW), Agilysys (AGYS), Digimarc (DMRC), Aerohive Networks (HIVE), Pareteum (TEUM), Travelzoo (TZOO), Asure Software (ASUR), Borqs Technologies (BRQS), AgriVest Americas (NXCN) and CSP (CSPI).
Who are Simulations Plus' key executives?
Simulations Plus' management team includes the folowing people:
- Mr. Walter S. Woltosz, Co-Founder & Chairman (Age 73)
- Mr. Shawn M. O'Connor, Chief Exec. Officer (Age 58)
- Mr. John R. Kneisel, Chief Financial Officer (Age 60)
- Ms. Cynthia Walawander, VP of Operations
- Ms. Virginia E. Woltosz, Sec. & Treasurer (Age 67)
Who are Simulations Plus' major shareholders?
Simulations Plus' stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (4.92%), Renaissance Technologies LLC (3.50%), Dimensional Fund Advisors LP (3.15%), William Blair Investment Management LLC (2.41%), Ancora Advisors LLC (2.13%) and Crawford Investment Counsel Inc. (1.85%). Company insiders that own Simulations Plus stock include Argenio David Z D, John Robert Kneisel, Thaddeus Henry Grasela Jr, Virginia E Woltosz and Walter S Woltosz. View Institutional Ownership Trends for Simulations Plus.
Which major investors are selling Simulations Plus stock?
SLP stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Crawford Investment Counsel Inc., Prudential Financial Inc. and Campbell & CO Investment Adviser LLC. Company insiders that have sold Simulations Plus company stock in the last year include John Robert Kneisel and Walter S Woltosz. View Insider Buying and Selling for Simulations Plus.
Which major investors are buying Simulations Plus stock?
SLP stock was bought by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., William Blair Investment Management LLC, First Light Asset Management LLC, Ancora Advisors LLC, Dimensional Fund Advisors LP, Cadence Capital Management LLC, Algert Global LLC and Bahl & Gaynor Inc.. View Insider Buying and Selling for Simulations Plus.
How do I buy shares of Simulations Plus?
Shares of SLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Simulations Plus' stock price today?
One share of SLP stock can currently be purchased for approximately $20.2625.
How big of a company is Simulations Plus?
Simulations Plus has a market capitalization of $352.24 million and generates $29.67 million in revenue each year. The technology company earns $8.93 million in net income (profit) each year or $0.50 on an earnings per share basis. Simulations Plus employs 95 workers across the globe.
What is Simulations Plus' official website?
How can I contact Simulations Plus?
Simulations Plus' mailing address is 42505 10TH STREET WEST, LANCASTER CA, 93534. The technology company can be reached via phone at 661-723-7723 or via email at [email protected]
MarketBeat Community Rating for Simulations Plus (NASDAQ SLP)
MarketBeat's community ratings are surveys of what our community members think about Simulations Plus and other stocks. Vote "Outperform" if you believe SLP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLP will underperform the S&P 500 over the long term. You may vote once every thirty days.
